Recent advances in the treatment of gastrointestinal stromal tumors. - Wikidata - wikimedia - TriplyDB

Recent advances in the treatment of gastrointestinal stromal tumors.

Recent advances in the treatment of gastrointestinal stromal tumors.

http://www.wikidata.org/entity/Q37704347

about

Endoscopic treatment for gastrointestinal stromal tumor: Advantages and hurdles Targeting cancer with kinase inhibitors Metastatic cerebellar gastrointestinal stromal tumor with obstructive hydrocephalus arising from the small intestine: a case report and review of the literature C-kit and PDGFRA gene mutations in triple negative breast cancer.Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial.Beyond standard therapy: drugs under investigation for the treatment of gastrointestinal stromal tumor.Comparison of Endoscopic and Open Resection for Small Gastric Gastrointestinal Stromal Tumor Giant and high-risk gastrointestinal stromal tumor in the abdomino-pelvic cavity: A case report.SEOM Clinical Guideline for gastrointestinal sarcomas (GIST) (2016).Adverse skeletal effects of drugs - beyond Glucocorticoids.An update on the safety and efficacy of regorafenib in the treatment of solid cancers.Regorafenib: A Review of Its Use in Patients with Advanced Gastrointestinal Stromal Tumours.Sorafenib: 10 years after the first pivotal trial.An innovative procedure of laparoscope combined with endoscopy for gastrointestinal stromal tumor resection and cholecystectomy: A case report and literature review.Clinical development landscape in GIST: from novel agents that target accessory pathways to revisiting non-targeted therapies.Partial response to imatinib treatment in a patient with unresectable gastrointestinal stromal tumor: A case report and mini literature review Novel Insights into the Treatment of Imatinib-Resistant Gastrointestinal Stromal Tumors.Merkel cell carcinoma of the lower leg with retroperitoneal GIST: a very rare association.The safety of regorafenib for the treatment of gastrointestinal stromal tumors.[Pharmacotherapy of solid tumors. New hopes and frustrations].Advances and Challenges on Management of Gastrointestinal Stromal Tumors.Gastroduodenal intussusception due to gastrointestinal stromal tumor

P2860

Q26822890-64F71047-3DE5-4B57-ABB7-BB074D15A7CF Q26865765-6774C3C3-4F8E-44AA-9DF8-39D8644EE86F Q30885557-6C1AB17F-9F1B-4C9A-BE2F-C58F605096AD Q34029247-AA114368-CE17-44CA-BD7A-6C3530EE58BB Q35895558-DAA92992-C2B1-4003-B39D-D32D673576C3 Q36125976-1AE27559-0EAF-42D3-9EF9-1258B57C2C56 Q36427502-891E6931-7E83-46D9-B2C5-5616D2C63A6F Q36640278-74D265DD-7850-4C5D-8E43-E73F7239D08F Q37475154-53E1DE59-724A-40FB-AC80-B1195763DD0D Q38231316-CE28079A-62D9-4382-87B3-0CEC2D222103 Q38260324-FB56CE12-60A1-4AC9-814B-56AA78DD144F Q38496239-9057A6DF-E60C-4CF2-BE2E-2867C915A003 Q38544841-157B5F24-CB59-4664-9CA4-DBF546ADCDAD Q38807146-6715C5FC-E8FD-4840-AE7F-26891A3AAA84 Q38925022-A60E0F0B-0F8D-4C51-B193-CCD5B3672CFE Q38971422-6B3C98E0-868B-4C26-9207-82727D5FA835 Q39288497-23F14CCB-52AA-42B7-BB1A-908A18DA6F8D Q51027510-17FF0400-9736-46F5-8F76-933C83DD0366 Q53805901-61BACA20-5980-453E-9639-5F8CBB099786 Q54328499-65D6B9BB-289E-4747-BEA5-9EC2742B03A0 Q55263134-3A721182-F591-4840-959F-50DCA7FE7DE1 Q59136957-041F315C-FEBF-4CC4-AADC-8D716B3FCDE9

P2860

Recent advances in the treatment of gastrointestinal stromal tumors.

http://www.wikidata.org/entity/Q37704347

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Recent advances in the treatment of gastrointestinal stromal tumors.

@en

Recent advances in the treatment of gastrointestinal stromal tumors.

@nl

type

label

Recent advances in the treatment of gastrointestinal stromal tumors.

@en

Recent advances in the treatment of gastrointestinal stromal tumors.

@nl

prefLabel

Recent advances in the treatment of gastrointestinal stromal tumors.

@en

Recent advances in the treatment of gastrointestinal stromal tumors.

@nl

P1433

Q37704347-3D950C90-087F-4AB6-B73D-7A4C2D5EB7B1

P1476

Q37704347-C0036653-E854-49B6-84AC-29EFAC2F3AC0

P2093

Q37704347-0CBD54DC-87EC-485E-BF57-96FD3BB46437

Q37704347-66F35BD1-60DB-4922-8D9C-6C52E9C774B8

P2860

Q37704347-064521EA-1912-4DDD-8839-737577CA951A

Q37704347-0672CAC7-37FF-4698-92B5-FE3936BFFF80

Q37704347-0A912F41-B06D-4D34-9B44-629CD138ADDA

Q37704347-0C9F549A-EA34-40A6-AE3B-3931D9D6DFF7

Q37704347-12C617B4-F5DF-418A-AC44-597A89C1410E

Q37704347-168E12A2-D24F-4F45-A057-780B141B376C

Q37704347-1BEB8B37-5BDD-4696-AFB0-53378AC96413

Q37704347-24DC28A7-F169-4704-869D-83F9FF92129B

Q37704347-254F9A81-E80F-4789-AAD7-3E2952600CA8

Q37704347-25BA2EDE-EF38-4A4A-A48A-016611F208BE

P304

Q37704347-9FD82FE0-CA40-4D33-ADA3-B482DC29C5B8

P31

Q37704347-8B139738-A677-47AC-9F5A-CABA79980601

P356

Q37704347-62224A6B-BEBC-4A6D-81E8-45129B8BC442

P433

Q37704347-D68D392A-5056-4670-BABC-B53C6640A40F

P478

Q37704347-013E147D-B285-48DD-832D-546062B9075F

P577

Q37704347-8A19E818-0C58-443E-A869-204FA58AF9E3

P698

Q37704347-74CD3BEF-4EF6-417B-AE8B-A28482525D81

P932

Q37704347-B193AD76-EFDE-4A9B-8D8C-74357F50D989

P356

1758834014522491

P1433

Therapeutic advances in medical oncology

P1476

Recent advances in the treatment of gastrointestinal stromal tumors.

@en

P2093

César Serrano

http://www.w3.org/2001/XMLSchema#string

Suzanne George

http://www.w3.org/2001/XMLSchema#string

P2860

BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models

Conformational Control Inhibition of the BCR-ABL1 Tyrosine Kinase, Including the Gatekeeper T315I Mutant, by the Switch-Control Inhibitor DCC-2036

Molecular correlates of imatinib resistance in gastrointestinal stromal tumors.

KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size.

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.

PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib.

Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor

Crenolanib inhibits the drug-resistant PDGFRA D842V mutation associated with imatinib-resistant gastrointestinal stromal tumors.

Ponatinib in refractory Philadelphia chromosome-positive leukemias.

A potent combination of the novel PI3K Inhibitor, GDC-0941, with imatinib in gastrointestinal stromal tumor xenografts: long-lasting responses after treatment withdrawal.

P304

115-127

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1758834014522491

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24790651

http://www.w3.org/2001/XMLSchema#string

P932

3987653

http://www.w3.org/2001/XMLSchema#string